BiondVax to Present at Biotech Showcase 2023
JERUSALEM, 05, 2023 (GLOBE NEWSWIRE) — via InvestorWire – BiondVax Pharmaceuticals (Nasdaq: BVXV), a biotechnology company focused on developing, manufacturing, and commercializing innovative immunotherapeutic products primarily for the treatment of infectious and autoimmune diseases, announced today that Amir…
Read More